Ангиогенеза (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ангиогенеза" in Serbian language version.

refsWebsite

Global rank Serbian rank

49doi.org

2^nd place

4^th place

41nih.gov

4^th place

8^th place

13semanticscholar.org

11^th place

23^rd place

12archive.org

6^th place

5^th place

4worldcat.org

5^th place

12^th place

3harvard.edu

18^th place

28^th place

2web.archive.org

1^st place

1ptca.org

low place

1unidu.hr

low place

1archive.today

14^th place

22^nd place

1ahajournals.org

3,608^th place

3,815^th place

1sagepub.com

731^st place

793^rd place

1meduniver.com

low place

1molecularonc.com

low place

ahajournals.org

circ.ahajournals.org

Simons, M; Bonow, RO; Chronos, NA (12. 9. 2000). „Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary”. Circulation. 102 (11): E73—86. PMID 10982554. S2CID 18060333. doi:10.1161/01.cir.102.11.e73. Архивирано из оригинала 10. 07. 2012. г. Приступљено 18. 6. 2009.

archive.org

Greenblatt, M.; Shubik,P (1968). „Tumor Angiogenesis: Trans filter diffusion studies by the transparent chamber technique”. J. Natl Cancer Inst. 41: 111—124.
Beck Jr, L.; d'Amore, P. A. (1997). „Vascular development: Cellular and molecular regulation”. FASEB J. 11 (5): 365—373. PMID 9141503. S2CID 14354316. doi:10.1096/fasebj.11.5.9141503. .
Buschmann, Ivo; Schaper, Wolfgang (2000). „The pathophysiology of the collateral circulation (Arteriogenesis)”. J Pathol. 190 (3): 338—342. PMID 10685067. S2CID 20457153. doi:10.1002/(SICI)1096-9896(200002)190:3<338::AID-PATH594>3.0.CO;2-7. .
Sluimer, J. C.; Daemen MJ. (2009). „Novel concepts in atherogenesis: angiogenesis and hypoxia in atherosclerosis”. J Pathol. 218 (1): 7—29. PMID 19309025. S2CID 206323906. doi:10.1002/path.2518. .
Lee, Sang H.; Wolf, Paul L.; Escudero, Ryan; Deutsch, Reena; Jamieson, Stuart W.; Thistlethwaite, Patricia A. (2. 3. 2000). „Early Expression of Angiogenesis Factors in Acute Myocardial Ischemia and Infarction”. New England Journal of Medicine. 342 (9): 626—633. PMID 10699162. doi:10.1056/NEJM200003023420904.
Gibson, C. M.; Ryan, K.; Sparano, A.; Moynihan, J. L.; Rizzo, M.; Kelley, M.; Marble, S. J.; Laham, R.; Simons, M.; McClusky, T. R.; Dodge Jr, J. T. (1999). „Angiographic methods to assess human coronary angiogenesis”. American Heart Journal. 137 (1): 169—179. PMID 9878950. doi:10.1016/S0002-8703(99)70473-4. .
Sasayama, S.; Fujita M. (1992). „Recent insights into coronary collateral circulation”. Circulation. 85 (3): 1197—1204. PMID 1371432. doi:10.1161/01.CIR.85.3.1197. .
Hublica, O; Brown, M; Egginton, S (1992). „Angiogenesis in skeletal and cardiac muscle”. Physiol Rev. 72 (2): 369—417. PMID 1372998. doi:10.1152/physrev.1992.72.2.369.
Gasparini, G.; Harris, A. L. (1995). „Clinical importance of the determination of tumor angiogenesis in breast carcinoma: Much more than a new prognostic tool”. J Clin Oncol. 13 (3): 765—82. PMID 7533829. doi:10.1200/JCO.1995.13.3.765. .
Folkman, J. (1974). „Proceedings: Tumor angiogenesis factor”. Cancer Res. 34 (8): 2109—2113. PMID 4842257.
Folkman, J. (1996). „Fighting cancer by attacking its blood supply”. Sci Am. 275 (3): 150—154. Bibcode:1996SciAm.275c.150F. PMID 8701285. doi:10.1038/scientificamerican0996-150.
Benny, O.; Fainaru, O.; Adini, A.; Cassiola, F.; Bazinet, L.; Adini, I.; Pravda, E.; Nahmias, Y.; Koirala, S.; Corfas, G.; d'Amato, R. J.; Folkman, J. (2008). „An orally delivered small-molecule formulation with antiangiogenic and anticancer activity”. Nature Biotechnology. 26 (7): 799—807. PMC 2803109 . PMID 18587385. doi:10.1038/nbt1415.

archive.today

Simons, M; Bonow, RO; Chronos, NA (12. 9. 2000). „Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary”. Circulation. 102 (11): E73—86. PMID 10982554. S2CID 18060333. doi:10.1161/01.cir.102.11.e73. Архивирано из оригинала 10. 07. 2012. г. Приступљено 18. 6. 2009.

doi.org

Sheikh, A. Y.; Rollins, M. D.; Hopf, H. W.; Hunt, T. K. (2005). „Hyperoxia improves microvascular perfusion in a murine wound model”. Wound Repair Regen. 13 (3): 303—308. PMID 15953050. S2CID 41125679. doi:10.1111/j.1067-1927.2005.130313.x. .
Ware, J. A.; Simons, M. (1997). „Angiogenesis in ischemic heart disease”. Nature Medicine. 3 (2): 158—164. PMID 9018233. S2CID 13466078. doi:10.1038/nm0297-158. .
Ferrara, N.; Alitalo, K. (1999). „Clinical applications of angiogenic growth factors and their inhibitors”. Nature Medicine. 5 (12): 1359—1364. PMID 10581076. S2CID 23537988. doi:10.1038/70928. .
Beck Jr, L.; d'Amore, P. A. (1997). „Vascular development: Cellular and molecular regulation”. FASEB J. 11 (5): 365—373. PMID 9141503. S2CID 14354316. doi:10.1096/fasebj.11.5.9141503. .
Asahara, T.; Masuda, H.; Takahashi, T.; Kalka, C.; Pastore, C.; Silver, M.; Kearne, M.; Magner, M.; Isner, J. M. (1999). „Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization”. Circ Res. 85 (3): 221—228. PMID 10436164. S2CID 1812414. doi:10.1161/01.RES.85.3.221. .
Buschmann, Ivo; Schaper, Wolfgang (2000). „The pathophysiology of the collateral circulation (Arteriogenesis)”. J Pathol. 190 (3): 338—342. PMID 10685067. S2CID 20457153. doi:10.1002/(SICI)1096-9896(200002)190:3<338::AID-PATH594>3.0.CO;2-7. .
Bisht, M.; Dhasmana, D. C.; Bist, S. S. (2010). „Angiogenesis: Future of pharmacological modulation”. Indian J Pharmacol. 42 (1): 2—8. PMC 2885631 . PMID 20606828. doi:10.4103/0253-7613.62395 .
Van Der Vorst, Emiel P.C.; Keijbeck, Anke A.; De Winther, Menno P.J.; Donners, Marjo M.P.C. (2012). „A disintegrin and metalloproteases: Molecular scissors in angiogenesis, inflammation and atherosclerosis”. Atherosclerosis. 224 (2): 302—8. PMID 22698791. doi:10.1016/j.atherosclerosis.2012.04.023. .
Ho-Tin-Noé, B.; Michel, J. B. (2011). „Initiation of angiogenesis in atherosclerosis: Smooth muscle cells as mediators of the angiogenic response to atheroma formation”. Trends Cardiovasc Med. 21 (7): 183—7. PMID 22867696. doi:10.1016/j.tcm.2012.05.007. .
Simons, M; Bonow, RO; Chronos, NA (12. 9. 2000). „Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary”. Circulation. 102 (11): E73—86. PMID 10982554. S2CID 18060333. doi:10.1161/01.cir.102.11.e73. Архивирано из оригинала 10. 07. 2012. г. Приступљено 18. 6. 2009.
Chhokar, Vikram; Tucker, Amy L. (2003). „Angiogenesis: Basic Mechanisms and Clinical Applications”. Seminars in Cardiothoracic and Vascular Anesthesia. 7 (3): 253—280. S2CID 72443585. doi:10.1177/108925320300700304. Abstract]
Bisht, Manisha; Dhasmana, DC; Bist, SS (2010). „Angiogenesis: Future of pharmacological modulation”. Indian J Pharmacol. 42 (1): 2—8. PMC 2885631 . PMID 20606828. doi:10.4103/0253-7613.62395 . .
Sluimer, J. C.; Daemen MJ. (2009). „Novel concepts in atherogenesis: angiogenesis and hypoxia in atherosclerosis”. J Pathol. 218 (1): 7—29. PMID 19309025. S2CID 206323906. doi:10.1002/path.2518. .
Michel, J. B.; Virmani, R; Arbustini, E.; Pasterkamp G. (2011). „Intraplaque haemorrhages as the trigger of plaque vulnerability.”. European Heart Journal. 32 (16): 1977—85. PMC 3155759 . PMID 21398643. doi:10.1093/eurheartj/ehr054. .
Sabia, P. J.; Powers, E. R.; Ragosta, M; Sarembock, I. J.; Burwell, L. R.; Kaul S. (1992). „An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction.”. New England Journal of Medicine. 327 (26): 1825—1831. PMID 1448120. doi:10.1056/NEJM199212243272601.
Semenza GL. (1998). „Hypoxia-inducible factor 1: master regulator of O2 homeostasis.”. Curr Opin Genet Dev. 8 (5): 588—594. PMID 9794818. doi:10.1016/S0959-437X(98)80016-6.
Jiang, B. H.; Zheng, J. Z.; Leung, S. W.; Roe, R; Semenza GL. (1997). „Transactivation and inhibitory domains of hypoxia-inducible factor 1α: modulation of transcriptional activity by oxygen tension.”. J Biol Chem. 272 (31): 19253—19260. PMID 9235919. doi:10.1074/jbc.272.31.19253 .
Wood, S. M.; Gleadle, J. M.; Pugh, C. W.; Hankinson, O; Ratcliffe PJ. (1996). „The role of the aryl hydrocarbon receptor nuclear translocator (ARNT) in hypoxic induction of gene expression: studies in ARNT-deficient cells.”. J Biol Chem. 271 (25): 15117—15123. PMID 8662957. doi:10.1074/jbc.271.25.15117 .
Rowlands, J. C.; Gustafsson JA. (1997). „Aryl hydrocarbon receptor-mediated signal transduction.”. Crit Rev Toxicol. 27 (2): 109—134. PMID 9099515. doi:10.3109/10408449709021615.
Lee, Sang H.; Wolf, Paul L.; Escudero, Ryan; Deutsch, Reena; Jamieson, Stuart W.; Thistlethwaite, Patricia A. (2. 3. 2000). „Early Expression of Angiogenesis Factors in Acute Myocardial Ischemia and Infarction”. New England Journal of Medicine. 342 (9): 626—633. PMID 10699162. doi:10.1056/NEJM200003023420904.
Wang GL, Jiang BH, Rue EA, Semenza GL (1995). „Hypoxia-inducible factor 1 is a basic helix-loop-helix-PAS heterodimer regulated by cellular O2 tension”. Proc. Natl. Acad. Sci. U.S.A. 92 (12): 5510—4. Bibcode:1995PNAS...92.5510W. PMC 41725 . PMID 7539918. doi:10.1073/pnas.92.12.5510 .
Jiang BH, Rue E, Wang GL, Roe R, Semenza GL (1996). „Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1”. J. Biol. Chem. 271 (30): 17771—8. PMID 8663540. doi:10.1074/jbc.271.30.17771 .
Folkman, J.; Klagsbrun, M. (1987). „Angiogenic factors”. Science. 235 (4787): 442—447. PMID 2432664. doi:10.1126/science.2432664.
Schumacher, B.; Pecher, P.; von Specht, B. U.; Stegmann, T. (1998). „Induction of neoangiogenesis in ischemic myocardium by human growth factors: First clinical results of a new treatment of coronary heart disease”. Circulation. 97 (7): 645—650. PMID 9495299. S2CID 11245275. doi:10.1161/01.CIR.97.7.645.
White, F C; Carroll, S M; Magnet, A; Bloor, C M (1992). „Coronary collateral development in swine after coronary artery occlusion.”. Circulation Research. 71 (6): 1490—1500. ISSN 0009-7330. doi:10.1161/01.res.71.6.1490.
Wolf, C.; Cai, W. J.; Vosschulte, R.; et al. (1998). „Vascular remodeling and altered protein expression during growth of coronary collateral arteries.”. J Mol Cell Cardiol. 30 (11): 2291—2305. PMID 9925366. doi:10.1006/jmcc.1998.0790.
Gibson, C. M.; Ryan, K.; Sparano, A.; Moynihan, J. L.; Rizzo, M.; Kelley, M.; Marble, S. J.; Laham, R.; Simons, M.; McClusky, T. R.; Dodge Jr, J. T. (1999). „Angiographic methods to assess human coronary angiogenesis”. American Heart Journal. 137 (1): 169—179. PMID 9878950. doi:10.1016/S0002-8703(99)70473-4. .
Sasayama, S.; Fujita M. (1992). „Recent insights into coronary collateral circulation”. Circulation. 85 (3): 1197—1204. PMID 1371432. doi:10.1161/01.CIR.85.3.1197. .
Hublica, O; Brown, M; Egginton, S (1992). „Angiogenesis in skeletal and cardiac muscle”. Physiol Rev. 72 (2): 369—417. PMID 1372998. doi:10.1152/physrev.1992.72.2.369.
Hanahan, D; Folkman, J (1996). „Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis”. Cell. 86 (3): 353—364. PMID 8756718. S2CID 8678765. doi:10.1016/S0092-8674(00)80108-7.
Li, J.; Post, M.; Volk, R.; Gao, Y.; Li, M.; Metais, C.; Sato, K.; Tsai, J.; Aird, W.; Rosenberg, R. D.; Hampton, T. G.; Sellke, F.; Carmeliet, P.; Simons, M. (2000). „PR39, a peptide regulator of angiogenesis”. Nature Medicine. 6 (1): 49—55. PMID 10613823. S2CID 21903014. doi:10.1038/71527. .
Jones, M. K.; Wang, H.; Peskar, B. M.; Levin, E.; Itani, R. M.; Sarfeh, I. J.; Tarnawski, A. S. (1999). „Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing”. Nature Medicine. 5 (12): 1418—1423. PMID 10581086. S2CID 32304338. doi:10.1038/70995.
Folkman, J. (1995). „Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis”. New England Journal of Medicine. 333 (26): 1757—63. PMID 7491141. doi:10.1056/NEJM199512283332608. .
Folkman, J.; Shing, Y. (1992). „Angiogenesis”. J Biol Chem. 267 (16): 10931—4. PMID 1375931. doi:10.1016/S0021-9258(19)49853-0 . .
Gasparini, G.; Harris, A. L. (1995). „Clinical importance of the determination of tumor angiogenesis in breast carcinoma: Much more than a new prognostic tool”. J Clin Oncol. 13 (3): 765—82. PMID 7533829. doi:10.1200/JCO.1995.13.3.765. .
Ahn, Anna; Frishman, William H.; Gutwein, Andrew; Passeri, Jonathan; Nelson, Michael (2008). „Therapeutic Angiogenesis”. Cardiology in Review. 16 (5): 219—229. ISSN 1061-5377. doi:10.1097/crd.0b013e3181620e50.
Risau, Werner; Marti, Hugo H. (1999). „Angiogenesis in Ischemic Disease”. Thrombosis and Haemostasis. 82 (S 01): 44—52. ISSN 0340-6245. doi:10.1055/s-0037-1615552.
Klencke, B. J. (2008). „Independent review of E2100 progression-free survival (PFS) with the addition of bevacizumab (B) to paclitaxel (P) as initial chemotherapy for metastatic breast cancer (MBC)”. J Clin Oncol. 26 (15_suppl): 1036. doi:10.1200/jco.2008.26.15_suppl.1036.
Folkman, J, Klagsbrun, M (1987). „Angiogenetic Factors”. Science. 235 (4787): 442—447. Bibcode:1987Sci...235..442F. PMID 2432664. doi:10.1126/science.2432664.
Folkman, J. (1996). „Fighting cancer by attacking its blood supply”. Sci Am. 275 (3): 150—154. Bibcode:1996SciAm.275c.150F. PMID 8701285. doi:10.1038/scientificamerican0996-150.
Benny, O.; Fainaru, O.; Adini, A.; Cassiola, F.; Bazinet, L.; Adini, I.; Pravda, E.; Nahmias, Y.; Koirala, S.; Corfas, G.; d'Amato, R. J.; Folkman, J. (2008). „An orally delivered small-molecule formulation with antiangiogenic and anticancer activity”. Nature Biotechnology. 26 (7): 799—807. PMC 2803109 . PMID 18587385. doi:10.1038/nbt1415.
Kerbel, Robert S. (2000). „Tumor angiogenesis: past, present and the near future”. Carcinogenesis. 21 (3): 505—515. ISSN 1460-2180. doi:10.1093/carcin/21.3.505.
Stewart, D. J.; Kutryk, M. J.; Fitchett, D.; Freeman, M.; Camack, N.; Su, Y.; Della Siega, A.; Bilodeau, L.; Burton, J. R.; Proulx, G.; Radhakrishnan, S.; NORTHERN Trial Investigators (јун 2009). „VEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: Results of the NORTHERN trial”. Mol Ther. 17 (6): 1109—15. PMC 2835194 . PMID 19352324. doi:10.1038/mt.2009.70.
Bianco, C.; Strizzi, L.; Ebert, A.; Chang, C.; Rehman, A.; Normanno, N.; Guedez, L.; Salloum, R.; Ginsburg, E.; Sun, Y.; Khan, N.; Hirota, M.; Wallace-Jones, B.; Wechselberger, C.; Vonderhaar, B. K.; Tosato, G.; Stetler-Stevenson, W. G.; Sanicola, M.; Salomon, D. S. (2005). „Role of human cripto-1 in tumor angiogenesis”. J Natl Cancer Inst. 97 (2): 132—41. PMID 15657343. doi:10.1093/jnci/dji011. .
Rhoads, K.; Arderiu, G.; Charboneau, A.; Hansen, S. L.; Hoffman, W.; Boudreau, N. (2005). „A role for Hox A5 in regulating angiogenesis and vascular patterning”. Lymphat Res Biol. 3 (4): 240—52. PMID 16379594. doi:10.1089/lrb.2005.3.240. .

dx.doi.org

White, F C; Carroll, S M; Magnet, A; Bloor, C M (1992). „Coronary collateral development in swine after coronary artery occlusion.”. Circulation Research. 71 (6): 1490—1500. ISSN 0009-7330. doi:10.1161/01.res.71.6.1490.
Ahn, Anna; Frishman, William H.; Gutwein, Andrew; Passeri, Jonathan; Nelson, Michael (2008). „Therapeutic Angiogenesis”. Cardiology in Review. 16 (5): 219—229. ISSN 1061-5377. doi:10.1097/crd.0b013e3181620e50.
Risau, Werner; Marti, Hugo H. (1999). „Angiogenesis in Ischemic Disease”. Thrombosis and Haemostasis. 82 (S 01): 44—52. ISSN 0340-6245. doi:10.1055/s-0037-1615552.
Kerbel, Robert S. (2000). „Tumor angiogenesis: past, present and the near future”. Carcinogenesis. 21 (3): 505—515. ISSN 1460-2180. doi:10.1093/carcin/21.3.505.

harvard.edu

adsabs.harvard.edu

Wang GL, Jiang BH, Rue EA, Semenza GL (1995). „Hypoxia-inducible factor 1 is a basic helix-loop-helix-PAS heterodimer regulated by cellular O2 tension”. Proc. Natl. Acad. Sci. U.S.A. 92 (12): 5510—4. Bibcode:1995PNAS...92.5510W. PMC 41725 . PMID 7539918. doi:10.1073/pnas.92.12.5510 .
Folkman, J, Klagsbrun, M (1987). „Angiogenetic Factors”. Science. 235 (4787): 442—447. Bibcode:1987Sci...235..442F. PMID 2432664. doi:10.1126/science.2432664.
Folkman, J. (1996). „Fighting cancer by attacking its blood supply”. Sci Am. 275 (3): 150—154. Bibcode:1996SciAm.275c.150F. PMID 8701285. doi:10.1038/scientificamerican0996-150.

meduniver.com

Роль цитокинов в ангиогенезе опухоли. на:MEDUNIVER ДЕРМАТОЛОГИЯ

molecularonc.com

„Biology and Clinical Applications of Angiogenesis Inhibition in Malignant Disease”. Molecular Oncology. 1 (2). пролеће 2007. Архивирано из оригинала 30. 12. 2012. г. Приступљено 25. 06. 2011.

nih.gov

ncbi.nlm.nih.gov

„Endoderm”. Endoderm -- Developmental Biology -- NCBI Bookshelf. Sinauer Associates. 2000. Приступљено 26. 6. 2010.
Sheikh, A. Y.; Rollins, M. D.; Hopf, H. W.; Hunt, T. K. (2005). „Hyperoxia improves microvascular perfusion in a murine wound model”. Wound Repair Regen. 13 (3): 303—308. PMID 15953050. S2CID 41125679. doi:10.1111/j.1067-1927.2005.130313.x. .
Ware, J. A.; Simons, M. (1997). „Angiogenesis in ischemic heart disease”. Nature Medicine. 3 (2): 158—164. PMID 9018233. S2CID 13466078. doi:10.1038/nm0297-158. .
Ferrara, N.; Alitalo, K. (1999). „Clinical applications of angiogenic growth factors and their inhibitors”. Nature Medicine. 5 (12): 1359—1364. PMID 10581076. S2CID 23537988. doi:10.1038/70928. .
Beck Jr, L.; d'Amore, P. A. (1997). „Vascular development: Cellular and molecular regulation”. FASEB J. 11 (5): 365—373. PMID 9141503. S2CID 14354316. doi:10.1096/fasebj.11.5.9141503. .
Asahara, T.; Masuda, H.; Takahashi, T.; Kalka, C.; Pastore, C.; Silver, M.; Kearne, M.; Magner, M.; Isner, J. M. (1999). „Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization”. Circ Res. 85 (3): 221—228. PMID 10436164. S2CID 1812414. doi:10.1161/01.RES.85.3.221. .
Buschmann, Ivo; Schaper, Wolfgang (2000). „The pathophysiology of the collateral circulation (Arteriogenesis)”. J Pathol. 190 (3): 338—342. PMID 10685067. S2CID 20457153. doi:10.1002/(SICI)1096-9896(200002)190:3<338::AID-PATH594>3.0.CO;2-7. .
Bisht, M.; Dhasmana, D. C.; Bist, S. S. (2010). „Angiogenesis: Future of pharmacological modulation”. Indian J Pharmacol. 42 (1): 2—8. PMC 2885631 . PMID 20606828. doi:10.4103/0253-7613.62395 .
Van Der Vorst, Emiel P.C.; Keijbeck, Anke A.; De Winther, Menno P.J.; Donners, Marjo M.P.C. (2012). „A disintegrin and metalloproteases: Molecular scissors in angiogenesis, inflammation and atherosclerosis”. Atherosclerosis. 224 (2): 302—8. PMID 22698791. doi:10.1016/j.atherosclerosis.2012.04.023. .
Ho-Tin-Noé, B.; Michel, J. B. (2011). „Initiation of angiogenesis in atherosclerosis: Smooth muscle cells as mediators of the angiogenic response to atheroma formation”. Trends Cardiovasc Med. 21 (7): 183—7. PMID 22867696. doi:10.1016/j.tcm.2012.05.007. .
Simons, M; Bonow, RO; Chronos, NA (12. 9. 2000). „Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary”. Circulation. 102 (11): E73—86. PMID 10982554. S2CID 18060333. doi:10.1161/01.cir.102.11.e73. Архивирано из оригинала 10. 07. 2012. г. Приступљено 18. 6. 2009.
Bisht, Manisha; Dhasmana, DC; Bist, SS (2010). „Angiogenesis: Future of pharmacological modulation”. Indian J Pharmacol. 42 (1): 2—8. PMC 2885631 . PMID 20606828. doi:10.4103/0253-7613.62395 . .
Sluimer, J. C.; Daemen MJ. (2009). „Novel concepts in atherogenesis: angiogenesis and hypoxia in atherosclerosis”. J Pathol. 218 (1): 7—29. PMID 19309025. S2CID 206323906. doi:10.1002/path.2518. .
Michel, J. B.; Virmani, R; Arbustini, E.; Pasterkamp G. (2011). „Intraplaque haemorrhages as the trigger of plaque vulnerability.”. European Heart Journal. 32 (16): 1977—85. PMC 3155759 . PMID 21398643. doi:10.1093/eurheartj/ehr054. .
Sabia, P. J.; Powers, E. R.; Ragosta, M; Sarembock, I. J.; Burwell, L. R.; Kaul S. (1992). „An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction.”. New England Journal of Medicine. 327 (26): 1825—1831. PMID 1448120. doi:10.1056/NEJM199212243272601.
Semenza GL. (1998). „Hypoxia-inducible factor 1: master regulator of O2 homeostasis.”. Curr Opin Genet Dev. 8 (5): 588—594. PMID 9794818. doi:10.1016/S0959-437X(98)80016-6.
Jiang, B. H.; Zheng, J. Z.; Leung, S. W.; Roe, R; Semenza GL. (1997). „Transactivation and inhibitory domains of hypoxia-inducible factor 1α: modulation of transcriptional activity by oxygen tension.”. J Biol Chem. 272 (31): 19253—19260. PMID 9235919. doi:10.1074/jbc.272.31.19253 .
Wood, S. M.; Gleadle, J. M.; Pugh, C. W.; Hankinson, O; Ratcliffe PJ. (1996). „The role of the aryl hydrocarbon receptor nuclear translocator (ARNT) in hypoxic induction of gene expression: studies in ARNT-deficient cells.”. J Biol Chem. 271 (25): 15117—15123. PMID 8662957. doi:10.1074/jbc.271.25.15117 .
Rowlands, J. C.; Gustafsson JA. (1997). „Aryl hydrocarbon receptor-mediated signal transduction.”. Crit Rev Toxicol. 27 (2): 109—134. PMID 9099515. doi:10.3109/10408449709021615.
Lee, Sang H.; Wolf, Paul L.; Escudero, Ryan; Deutsch, Reena; Jamieson, Stuart W.; Thistlethwaite, Patricia A. (2. 3. 2000). „Early Expression of Angiogenesis Factors in Acute Myocardial Ischemia and Infarction”. New England Journal of Medicine. 342 (9): 626—633. PMID 10699162. doi:10.1056/NEJM200003023420904.
Wang GL, Jiang BH, Rue EA, Semenza GL (1995). „Hypoxia-inducible factor 1 is a basic helix-loop-helix-PAS heterodimer regulated by cellular O2 tension”. Proc. Natl. Acad. Sci. U.S.A. 92 (12): 5510—4. Bibcode:1995PNAS...92.5510W. PMC 41725 . PMID 7539918. doi:10.1073/pnas.92.12.5510 .
Jiang BH, Rue E, Wang GL, Roe R, Semenza GL (1996). „Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1”. J. Biol. Chem. 271 (30): 17771—8. PMID 8663540. doi:10.1074/jbc.271.30.17771 .
Folkman, J.; Klagsbrun, M. (1987). „Angiogenic factors”. Science. 235 (4787): 442—447. PMID 2432664. doi:10.1126/science.2432664.
Schumacher, B.; Pecher, P.; von Specht, B. U.; Stegmann, T. (1998). „Induction of neoangiogenesis in ischemic myocardium by human growth factors: First clinical results of a new treatment of coronary heart disease”. Circulation. 97 (7): 645—650. PMID 9495299. S2CID 11245275. doi:10.1161/01.CIR.97.7.645.
Wolf, C.; Cai, W. J.; Vosschulte, R.; et al. (1998). „Vascular remodeling and altered protein expression during growth of coronary collateral arteries.”. J Mol Cell Cardiol. 30 (11): 2291—2305. PMID 9925366. doi:10.1006/jmcc.1998.0790.
Gibson, C. M.; Ryan, K.; Sparano, A.; Moynihan, J. L.; Rizzo, M.; Kelley, M.; Marble, S. J.; Laham, R.; Simons, M.; McClusky, T. R.; Dodge Jr, J. T. (1999). „Angiographic methods to assess human coronary angiogenesis”. American Heart Journal. 137 (1): 169—179. PMID 9878950. doi:10.1016/S0002-8703(99)70473-4. .
Sasayama, S.; Fujita M. (1992). „Recent insights into coronary collateral circulation”. Circulation. 85 (3): 1197—1204. PMID 1371432. doi:10.1161/01.CIR.85.3.1197. .
Hublica, O; Brown, M; Egginton, S (1992). „Angiogenesis in skeletal and cardiac muscle”. Physiol Rev. 72 (2): 369—417. PMID 1372998. doi:10.1152/physrev.1992.72.2.369.
Hanahan, D; Folkman, J (1996). „Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis”. Cell. 86 (3): 353—364. PMID 8756718. S2CID 8678765. doi:10.1016/S0092-8674(00)80108-7.
Li, J.; Post, M.; Volk, R.; Gao, Y.; Li, M.; Metais, C.; Sato, K.; Tsai, J.; Aird, W.; Rosenberg, R. D.; Hampton, T. G.; Sellke, F.; Carmeliet, P.; Simons, M. (2000). „PR39, a peptide regulator of angiogenesis”. Nature Medicine. 6 (1): 49—55. PMID 10613823. S2CID 21903014. doi:10.1038/71527. .
Jones, M. K.; Wang, H.; Peskar, B. M.; Levin, E.; Itani, R. M.; Sarfeh, I. J.; Tarnawski, A. S. (1999). „Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing”. Nature Medicine. 5 (12): 1418—1423. PMID 10581086. S2CID 32304338. doi:10.1038/70995.
Folkman, J. (1995). „Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis”. New England Journal of Medicine. 333 (26): 1757—63. PMID 7491141. doi:10.1056/NEJM199512283332608. .
Folkman, J.; Shing, Y. (1992). „Angiogenesis”. J Biol Chem. 267 (16): 10931—4. PMID 1375931. doi:10.1016/S0021-9258(19)49853-0 . .
Gasparini, G.; Harris, A. L. (1995). „Clinical importance of the determination of tumor angiogenesis in breast carcinoma: Much more than a new prognostic tool”. J Clin Oncol. 13 (3): 765—82. PMID 7533829. doi:10.1200/JCO.1995.13.3.765. .
Folkman, J. (1974). „Proceedings: Tumor angiogenesis factor”. Cancer Res. 34 (8): 2109—2113. PMID 4842257.
Folkman, J, Klagsbrun, M (1987). „Angiogenetic Factors”. Science. 235 (4787): 442—447. Bibcode:1987Sci...235..442F. PMID 2432664. doi:10.1126/science.2432664.
Folkman, J. (1996). „Fighting cancer by attacking its blood supply”. Sci Am. 275 (3): 150—154. Bibcode:1996SciAm.275c.150F. PMID 8701285. doi:10.1038/scientificamerican0996-150.
Benny, O.; Fainaru, O.; Adini, A.; Cassiola, F.; Bazinet, L.; Adini, I.; Pravda, E.; Nahmias, Y.; Koirala, S.; Corfas, G.; d'Amato, R. J.; Folkman, J. (2008). „An orally delivered small-molecule formulation with antiangiogenic and anticancer activity”. Nature Biotechnology. 26 (7): 799—807. PMC 2803109 . PMID 18587385. doi:10.1038/nbt1415.
Stewart, D. J.; Kutryk, M. J.; Fitchett, D.; Freeman, M.; Camack, N.; Su, Y.; Della Siega, A.; Bilodeau, L.; Burton, J. R.; Proulx, G.; Radhakrishnan, S.; NORTHERN Trial Investigators (јун 2009). „VEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: Results of the NORTHERN trial”. Mol Ther. 17 (6): 1109—15. PMC 2835194 . PMID 19352324. doi:10.1038/mt.2009.70.
Bianco, C.; Strizzi, L.; Ebert, A.; Chang, C.; Rehman, A.; Normanno, N.; Guedez, L.; Salloum, R.; Ginsburg, E.; Sun, Y.; Khan, N.; Hirota, M.; Wallace-Jones, B.; Wechselberger, C.; Vonderhaar, B. K.; Tosato, G.; Stetler-Stevenson, W. G.; Sanicola, M.; Salomon, D. S. (2005). „Role of human cripto-1 in tumor angiogenesis”. J Natl Cancer Inst. 97 (2): 132—41. PMID 15657343. doi:10.1093/jnci/dji011. .
Rhoads, K.; Arderiu, G.; Charboneau, A.; Hansen, S. L.; Hoffman, W.; Boudreau, N. (2005). „A role for Hox A5 in regulating angiogenesis and vascular patterning”. Lymphat Res Biol. 3 (4): 240—52. PMID 16379594. doi:10.1089/lrb.2005.3.240. .

ptca.org

(језик: енглески) Angeogenesis Overview Angioplasty.Org

sagepub.com

journals.sagepub.com

Chhokar, Vikram; Tucker, Amy L. (2003). „Angiogenesis: Basic Mechanisms and Clinical Applications”. Seminars in Cardiothoracic and Vascular Anesthesia. 7 (3): 253—280. S2CID 72443585. doi:10.1177/108925320300700304. Abstract]

semanticscholar.org

api.semanticscholar.org

Sheikh, A. Y.; Rollins, M. D.; Hopf, H. W.; Hunt, T. K. (2005). „Hyperoxia improves microvascular perfusion in a murine wound model”. Wound Repair Regen. 13 (3): 303—308. PMID 15953050. S2CID 41125679. doi:10.1111/j.1067-1927.2005.130313.x. .
Ware, J. A.; Simons, M. (1997). „Angiogenesis in ischemic heart disease”. Nature Medicine. 3 (2): 158—164. PMID 9018233. S2CID 13466078. doi:10.1038/nm0297-158. .
Ferrara, N.; Alitalo, K. (1999). „Clinical applications of angiogenic growth factors and their inhibitors”. Nature Medicine. 5 (12): 1359—1364. PMID 10581076. S2CID 23537988. doi:10.1038/70928. .
Beck Jr, L.; d'Amore, P. A. (1997). „Vascular development: Cellular and molecular regulation”. FASEB J. 11 (5): 365—373. PMID 9141503. S2CID 14354316. doi:10.1096/fasebj.11.5.9141503. .
Asahara, T.; Masuda, H.; Takahashi, T.; Kalka, C.; Pastore, C.; Silver, M.; Kearne, M.; Magner, M.; Isner, J. M. (1999). „Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization”. Circ Res. 85 (3): 221—228. PMID 10436164. S2CID 1812414. doi:10.1161/01.RES.85.3.221. .
Buschmann, Ivo; Schaper, Wolfgang (2000). „The pathophysiology of the collateral circulation (Arteriogenesis)”. J Pathol. 190 (3): 338—342. PMID 10685067. S2CID 20457153. doi:10.1002/(SICI)1096-9896(200002)190:3<338::AID-PATH594>3.0.CO;2-7. .
Simons, M; Bonow, RO; Chronos, NA (12. 9. 2000). „Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary”. Circulation. 102 (11): E73—86. PMID 10982554. S2CID 18060333. doi:10.1161/01.cir.102.11.e73. Архивирано из оригинала 10. 07. 2012. г. Приступљено 18. 6. 2009.
Chhokar, Vikram; Tucker, Amy L. (2003). „Angiogenesis: Basic Mechanisms and Clinical Applications”. Seminars in Cardiothoracic and Vascular Anesthesia. 7 (3): 253—280. S2CID 72443585. doi:10.1177/108925320300700304. Abstract]
Sluimer, J. C.; Daemen MJ. (2009). „Novel concepts in atherogenesis: angiogenesis and hypoxia in atherosclerosis”. J Pathol. 218 (1): 7—29. PMID 19309025. S2CID 206323906. doi:10.1002/path.2518. .
Schumacher, B.; Pecher, P.; von Specht, B. U.; Stegmann, T. (1998). „Induction of neoangiogenesis in ischemic myocardium by human growth factors: First clinical results of a new treatment of coronary heart disease”. Circulation. 97 (7): 645—650. PMID 9495299. S2CID 11245275. doi:10.1161/01.CIR.97.7.645.
Hanahan, D; Folkman, J (1996). „Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis”. Cell. 86 (3): 353—364. PMID 8756718. S2CID 8678765. doi:10.1016/S0092-8674(00)80108-7.
Li, J.; Post, M.; Volk, R.; Gao, Y.; Li, M.; Metais, C.; Sato, K.; Tsai, J.; Aird, W.; Rosenberg, R. D.; Hampton, T. G.; Sellke, F.; Carmeliet, P.; Simons, M. (2000). „PR39, a peptide regulator of angiogenesis”. Nature Medicine. 6 (1): 49—55. PMID 10613823. S2CID 21903014. doi:10.1038/71527. .
Jones, M. K.; Wang, H.; Peskar, B. M.; Levin, E.; Itani, R. M.; Sarfeh, I. J.; Tarnawski, A. S. (1999). „Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing”. Nature Medicine. 5 (12): 1418—1423. PMID 10581086. S2CID 32304338. doi:10.1038/70995.

unidu.hr

(језик: хрватски)Slađana Čulić Angogeneza tumorskog tkiva, No Slide Title Архивирано на сајту Wayback Machine (16. јануар 2014)

web.archive.org

(језик: хрватски)Slađana Čulić Angogeneza tumorskog tkiva, No Slide Title Архивирано на сајту Wayback Machine (16. јануар 2014)
„Biology and Clinical Applications of Angiogenesis Inhibition in Malignant Disease”. Molecular Oncology. 1 (2). пролеће 2007. Архивирано из оригинала 30. 12. 2012. г. Приступљено 25. 06. 2011.

worldcat.org

White, F C; Carroll, S M; Magnet, A; Bloor, C M (1992). „Coronary collateral development in swine after coronary artery occlusion.”. Circulation Research. 71 (6): 1490—1500. ISSN 0009-7330. doi:10.1161/01.res.71.6.1490.
Ahn, Anna; Frishman, William H.; Gutwein, Andrew; Passeri, Jonathan; Nelson, Michael (2008). „Therapeutic Angiogenesis”. Cardiology in Review. 16 (5): 219—229. ISSN 1061-5377. doi:10.1097/crd.0b013e3181620e50.
Risau, Werner; Marti, Hugo H. (1999). „Angiogenesis in Ischemic Disease”. Thrombosis and Haemostasis. 82 (S 01): 44—52. ISSN 0340-6245. doi:10.1055/s-0037-1615552.
Kerbel, Robert S. (2000). „Tumor angiogenesis: past, present and the near future”. Carcinogenesis. 21 (3): 505—515. ISSN 1460-2180. doi:10.1093/carcin/21.3.505.